Joanne Bauer Biography and Net Worth

Director of Omnicell

Joanne Bauer has served as a Director of Omnicell since January 2014. As a senior healthcare and CPG executive with extensive general management and P&L experience, Ms. Bauer has a successful track record growing global businesses. She has over 30 years’ experience with Kimberly-Clark Corporation, a Fortune 500 company, where she led the growth of its healthcare business. Ms. Bauer was the President of Health Care from 2001-2014, building the business to a successful spin from Kimberly-Clark in 2014 as a NYSE-traded company, Halyard Health. Ms. Bauer was instrumental in growing the Health Care business through acquisitions, innovation, international expansion, and restructuring the supply chain footprint.

Ms. Bauer is on the board of Advocate Aurora Health Care. She is also a member of The Committee of 200 (C200), and a founding member of Access Circles. She previously served on the Board of Directors of AdvaMed, the Advanced Medical Technology Association, and MedShare, a nonprofit organization providing medical supplies globally.

What is Joanne B. Bauer's net worth?: The estimated net worth of Joanne B. Bauer is at least $927,168.00 as of March 7th, 2023. Ms. Bauer owns 28,096 shares of Omnicell stock worth more than $927,168 as of March 15th. This net worth approximation does not reflect any other investments that Ms. Bauer may own. Learn More about Joanne B. Bauer's net worth.
How do I contact Joanne B. Bauer?: The corporate mailing address for Ms. Bauer and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at ir@omnicell.com. Learn More on Joanne B. Bauer's contact information.
Has Joanne B. Bauer been buying or selling shares of Omnicell?: Joanne B. Bauer has not been actively trading shares of Omnicell during the past quarter. Most recently, Joanne B. Bauer sold 13,115 shares of the business's stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $54.24, for a transaction totalling $711,357.60. Following the completion of the sale, the director now directly owns 28,096 shares of the company's stock, valued at $1,523,927.04. Learn More on Joanne B. Bauer's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Joanne Bauer (Director), Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Mark Parrish (Director), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, insiders at the sold shares 1 times. They sold a total of 12,000 shares worth more than $567,600.00. The most recent insider tranaction occured on December, 10th when Director Mark W Parrish sold 12,000 shares worth more than $567,600.00. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 12/10/2024.

Joanne B. Bauer Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2023	Sell	13,115	$54.24	$711,357.60	28,096
2/19/2020	Sell	2,919	$88.42	$258,097.98	18,835
5/14/2019	Sell	3,798	$81.72	$310,372.56	20,314

Joanne B. Bauer Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $33.00

$32.40

$33.47

50 Day Range

MA: $40.71

$32.28

$45.31

2 Week Range

Now: $33.00

$25.12

$55.75

Volume

828,624 shs

Average Volume

496,113 shs

Market Capitalization

$1.54 billion

P/E Ratio

122.23

Dividend Yield

N/A

Beta

0.85